Substance
AMBRISENTAN
Global reference: every product and company linked to this substance.
- cas: 177036-94-1
- ncit: C72694
- pubchem_cid: 6918493
- rxnorm: 358274
- unii: HW6NV07QEC
ambrisentan [INN] · AMBRISENTAN [JAN] · Ambrisentan [WHO-DD] · GSK-1325760 · GSK-1325760A · GSK1325760 · GSK1325760A · LETAIRIS · LU-208075 · VOLIBRIS
Revenue by product (1)
| Company | Product | Latest period | Revenue |
|---|---|---|---|
| GILEAD SCIENCES INC. COMMON STOCK | LETAIRIS | Q4 2023 | $36.0M |
A figure belongs to the product it was reported for. It is never summed across companies or across a company's products, so one substance in three products shows three figures.
Products containing this substance (2)
- AMBRISENTAN · VIATRIS INC. COMMON STOCK
- LETAIRIS · GILEAD SCIENCES INC. COMMON STOCK